Neurosense Therapeutics Ltd. (NRSN)
Market Open
12 Jun, 14:51
NASDAQ (CM) NASDAQ (CM) Primary 
XFRA $
0. 73
-0.01
-1.1908%
$
18.75M Market Cap
- P/E Ratio
- Div Yield
33,247 Volume
-0.8 Eps
$ 0.74
Previous Close Investors:
Want to track NRSN and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Neurosense Therapeutics Ltd. Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
| RJ Rebecca Judd Pathstone Holdings, LLC | 16,528 | $12,710 | $11,900.16 | -$809.84 | -6.37% |
